Hospital La Paz Institute for Health Research Spain Joins the BlueCloud Education Network
Hospital La Paz Institute for Health Research joining BlueCloud’s global movement for the standardization of accredited educational activities, using smart city building approaches, to improve human subject protection and patient safety globally.
AUSTIN, TEXAS (PRWEB) NOVEMBER 20, 2018
BlueCloud by HealthCarePoint (HCP), a Texas-based healthcare and clinical research networking technology company and Hospital La Paz Institute for Health Research (IdiPAZ) announced its mutual efforts to globally expand access to medical education opportunities. The collaboration involves IdiPAZ helping to modernize sites by using BlueCloud’s global Delivery, Distribution and Implementation (DDI™) mechanisms to ensure site quality assurance and transparency management of professional competencies in over 167 countries with a focus in underdeveloped countries including Africa, Asia and Latin America.
The adherence to newly established standards has been on the rise over the past couple of years due to regulatory requirements in healthcare and clinical research. As a national institution, IdiPAZ has led the way in improving care with standards as their guiding solution to treating stroke in the neuroscience world as well as other therapeutic areas. After scientific research and institutional analysis, the Madrid-DIRECT scale and the modernized version for the PedNIHSS standards of care were developed by IdiPAZ to benefit patients care. The Madrid-Direct scale was developed based on an observational study coordinated by IdiPAZ with the participation of the Madrid Stroke Network (a collaborative system of care promoted by the Madrid Association of Neurology), the Madrid Regional Health System (SERMAS) and the pre-hospital emergency system for the Madrid Region (SUMMA-112). The Madrid-DIRECT scale provides guidance about the suitability for endovascular treatment based on the information obtained from the pre-hospital evaluation and on the needs and organizational aspects of the Community of Madrid. The assessment is necessary due to an international need for paramedics and ER staff to adequately diagnose the severity of stroke patients needed to be sent to comprehensive stroke care facilities in order to avoid increased staff-care overload. Global healthcare and clinical research professionals will further be empowered to utilize the increased number of medical education courses from dozens of institutions who are currently using BlueCloud’s DDI™ mechanisms. With IdiPAZ becoming the newest members of the global BlueCloud network, BlueCloud systems can act as the vehicle for healthcare professionals to opt-in, own and globally share their required credentials and competencies between research sites, research sponsors and other healthcare organizations for business and regulatory requirements, minimizing redundancies, fraud, waste and abuse.
The focus of this collaboration also involves but not limited to: 1) helping to facilitate the global expansion of Madrid-DIRECT and the PedNIHSS by including them with well-established education standards distributed globally within the BlueCloud Network. 2) IdiPAZ’s staff will also be able to centralize their research accredited courses, competencies and shareable documents within BlueCloud personal accounts and connect with organizations for business and compliance in healthcare and clinical research; 3) Blend globally standardized certification programs like the NIH Stroke Scale, Rankin mRS, C-SSRS and many others, with IdiPAZ education activities, and distribute them to global investigator sites, national and international healthcare organizations, continuing to improve transparency, and human subject protection while following new GDPR Guidelines. 4) Maximize healthcare professionals’ educational opportunities in underdeveloped countries to help sponsors, universities and government organizations standardize patient recruitment and improve inter-rater-reliability in clinical research to ultimately save time, save money and save lives. 5) Provide smart city building BlueCloud DDI™ technologies and approaches to connect local industry stakeholders to the international healthcare and clinical research community for business and compliance purposes.
“The MADRID-DIRECT is used as a pre-hospital scale for the measurement of the probability of requiring mechanical thrombectomy, developed in close collaboration with the Madrid Stroke network. It allows Emergency Services to refer a patient directly to the corresponding Stroke Center based on clinical examination. Furthermore, a training course of the Spanish version of the PedNIHSS that was developed by a panel of pediatric and adult stroke experts to fill the current needs to improve the management of childhood stroke, will also be added to the global BlueCloud Education Network,” stated Exuperio Díez Tejedor, MD, PhD Head of Department of Neurology and Stroke Centre at La Paz University Hospital, Coordinator of Neurosciences Area and Director of the Neurology and Cerebrovascular Diseases Research Group at IdiPAZ, president Spanish Society of Neurology.
“We are very excited about this collaboration with such a prestigious organization. This collaboration will continue to expand BlueCloud’s global blueprint with dozens of independent and institutional members to further streamline the delivery, distribution and implementation (DDI™) of initiatives in developed and underdeveloped countries – Stated Al O. Pacino – President and Co-Founder of BlueCloud by HealthCarePoint. We continue to prove that when stakeholders place collaborations into practice, to focus on patients first, we can modernize systems and ultimately save more lives, time and resources. The effectiveness and outcomes of the distribution of standardized processes incentivizes culture change and modernizes the establishment by embracing real-time connectivity as a method of increasing access to quality care and getting drugs and medical devices to market faster.”
A global innovation providing Delivery, Distribution and Implementation (DDI™) mechanisms, managed from a single point, for all industry stakeholders. The BlueCloud® is a Connector Service Provider (CSP ®). Nominated as one of the top innovations in the industry, BlueCloud® is the first independent (real-time / single sign-on) Professional Network for Healthcare and Clinical Research. A global collaborative network and essential catalyst of the ACRES global system, connecting all stakeholders in a common, secure, regulated, private system. Available in 167 countries and used by over 1.5 million healthcare professionals from governments, sponsors, CROs, research sites, hospitals, universities, and thousands of other healthcare and clinical research stakeholders, using a centralized global system to connect, organize, centralize and share verifiable information in real-time for managerial and compliance activities. Now proven to save the industry millions of dollars by eliminating redundancies, expediting study start up, ensuring quality, transparency and compliance, modernizing the industry and thus – creating a common system that leaves no patient behind no matter what race, religion, socio-economic status, political affiliation or geographical location.
Hospital La Paz Institute for Health Research (IdiPAZ) was created in 2009 and is conceived as a biomedical research space resulting from the relationship between La Paz University Hospital (HULP), Fuenlabrada University Hospital (HUF), the Autonomous University of Madrid (UAM), and the Foundation for Biomedical Research of La Paz University Hospital (FIBHULP). IdiPAZ works to become a national and international reference in translational biomedical research, promoting quality research at basic, clinical, epidemiological and health services levels. Furthermore, our Institute is aimed at favoring and developing research programs and projects or training of researchers, with special attention to the scientific training of professionals in research methodology and the needs of the Primary Healthcare field. IdiPAZ’s scientific structure includes 55 research groups distributed according to six strategic areas: Neurosciences, Cardiovascular, Infectious Diseases and Immunity, Organ System Pathologies, Cancer and Human Molecular Genetics, and Surgery, Transplant and Health Technologies.